becomes a cash flow power house in your words. we think we re seeing the part of the possible and the buzz kill of the probable coming together the world s alarmer tam. the world s most energetic, enigmatic, courageous ceo. a phenomenal human being in many regards, and then against that, and also frankly the product has a huge lead on anything else in the market on the other side of that to extrapolate that out, 10 or 20 years, investors are making a number of bets they re betting on the legacy guys failing even if they spend half a trillion trying to succeed. and i think the big bet is against amazon, apple, and google nose are the things that concern us right now when you see the case there at 70, is there a symmetry on how good and bad it could get. if you lock most people in a room for a week or a month and say you need a $5,000 or $10,000 share price for tesla, they can dream the dream, right and you would have to have a path to get there. that may not be provable,
[inaudible conversations] good morning the subcommittee will now come to order. welcome to everyone that is here in the hearing room. the chair now recognizes herself for an opening statement. according to dhs national survey on drug use, 44 million americans reported using cannabis in the last year. thirty-three states now allow the medicinal use of cannabis and in the district of columbia have legalized for adult use. state laws and federal policy are 1000 miles apart. the federal government s still strictly prohibits even restricting legitimate medical research. widespread availability of cannabis is the purpose of the hearing to examine the pressing need for medical research of cannabis and the chemical compound with cbd being one of them. half a century ago the congress listed cannabis as schedule one substance including heroin heroine, lsd, and ecstasy. schedule one drugs have no medical value in high potential for abuse. scheduled to drugs such as cocaine and vicodi
[inaudible conversations] good morning the subcommittee will now come to order. welcome to everyone that is here in the hearing room. the chair now recognizes herself for an opening statement. according to dhs national survey on drug use, 44 million americans reported using cannabis in the last year. thirty-three states now allow the medicinal use of cannabis and in the district of columbia have legalized for adult use. state laws and federal policy are 1000 miles apart. the federal government s still strictly prohibits even restricting legitimate medical research. widespread availability of cannabis is the purpose of the hearing to examine the pressing need for medical research of cannabis and the chemical compound with cbd being one of them. half a century ago the congress listed cannabis as schedule one substance including heroin heroine, lsd, and ecstasy. schedule one drugs have no medical value in high potential for abuse. scheduled to drugs such as cocaine and vicodin
earnings would be about the same adds last year. not something wall street wanted to hear. they were expecting the si solid growth in profits. after that one disappointment came another. this one from comcast. who said competition is stiff and warned subscriptions would be down. it is no vet that media companies have been struggling as cherry picking viewers stream the traditional beefy bundles of cable tv channels. today, those concerns played out in the stock market and how. disney would you likely own in a mutual fund, retirement or individually was the worst we are forming dow stock today. comcast, the parent company of cnbc which produces this program was off more tg to other part o the media sector. julia boorsen takes a look. red flags from disney and comcast, making headlines out of the media conference today. i think what investors are worried about though is the pressure broadly on this group. so gerngs an environment where people are shooting first and asking q